Type : Bid Notification
Best Pharmaceuticals for Children Act (BPCA) Pediatric Trials Network (PTN)
Best Pharmaceuticals for Children Act (BPCA) Pediatric Trials Network (PTN)
Although the primary focus of this Contract is to support the Best Pharmaceuticals for Children Act-Pediatric Trials Network clinical activities, NICHD also anticipates the need to utilize this Contract to acquire similar types of support for other NICHD pediatric drug development activities.BPCA 2017 authorizes NICHD to identify therapeutic gaps in pediatrics, which are pediatric diseases, disorders or conditions where more complete knowledge and
2020.500-COVID-19 - BEST PHARMACEUTICALS FOR CHILDREN ACT PEDIATRIC TRIALS NETWORK - COVID-19 STUDIES Solicitation ID/Procurement Identifier: 75N94018D00003 Ultimate Completion Date: Wed Sep 20 17:00:00 GMT 2023
Offerors may propose any number of vaccines or presentations of Emergency Use Authorizations (EUA) and/or Biologics License Application (BLA) COVID-19 vaccines indicated for children 0 through 18 years of age. Offerors for this requirement must be manufacturers of pediatric vaccines in accordance with 42 U.S.C. § 1396s.
Service Act and Vaccine for Children (VFC) program, established pursuant to Section 13631 of the Omnibus Budget Reconciliation Act of 1993 (OBRA '93).Vaccines shall be delivered F.O.B.
Service Act and Vaccine for Children (VFC) program, established pursuant to Section 13631 of the Omnibus Budget Reconciliation Act of 1993 (OBRA '93).Vaccines shall be delivered F.O.B.
Territories) to support pediatric immunization programs as provided under Section 317(j) of the Public Health Service Act and Vaccine for Children (VFC) program, established pursuant to Section 13631 of the Omnibus Budget Reconciliation Act of 1993 (OBRA '93). Vaccines shall be delivered F.O.B. Destination to the 50 states and U.S. territories. The period of performance shall be 12 months from date of award.